Capital Expenditures for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current capital expenditures (TTM) is $2.17B USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$2.17B
YoY change
-1.6%
5Y CAGR
-0.1%
Peak year (2024)
$2.21B
Cumulative capital expenditures
$45.33B
CapEx history chart for Abbott Laboratories (ABT) from 1989 to 2025
CapEx history table for Abbott Laboratories (ABT) from 1989 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $2.17B | -1.6% | ||
| 2024 | $2.21B | +0.2% | ||
| 2023 | $2.20B | +23.9% | ||
| 2022 | $1.78B | -5.7% | ||
| 2021 | $1.89B | -13.4% | ||
| 2020 | $2.18B | +32.9% | ||
| 2019 | $1.64B | +17.5% | ||
| 2018 | $1.39B | +22.8% | ||
| 2017 | $1.14B | +1.2% | ||
| 2016 | $1.12B | +1.0% | ||
| 2015 | $1.11B | +3.1% | ||
| 2014 | $1.08B | -5.9% | ||
| 2013 | $1.15B | -36.2% | ||
| 2012 | $1.80B | +20.4% | ||
| 2011 | $1.49B | +46.9% | ||
| 2010 | $1.02B | -6.8% | ||
| 2009 | $1.09B | -15.4% | ||
| 2008 | $1.29B | -22.2% | ||
| 2007 | $1.66B | +23.8% | ||
| 2006 | $1.34B | +10.8% | ||
| 2005 | $1.21B | -6.5% | ||
| 2004 | $1.29B | +3.6% | ||
| 2003 | $1.25B | -3.8% | ||
| 2002 | $1.30B | +11.4% | ||
| 2001 | $1.16B | +12.3% | ||
| 2000 | $1.04B | +4.9% | ||
| 1999 | $987.10M | -20.6% | ||
| 1998 | $1.24B | +2.7% | ||
| 1997 | $1.21B | +27.5% | ||
| 1996 | $949.00M | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | -100.0% | ||
| 1992 | $1.01B | +30.7% | ||
| 1991 | $770.60M | +20.1% | ||
| 1990 | $641.40M | +11.9% | ||
| 1989 | $573.10M | — |
CapEx values are taken from Abbott Laboratories's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Abbott Laboratories (ABT) reported capital expenditures of $2.17B – edged down 1.6% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Abbott Laboratories capital expenditures compounded at -0.1% per year, with a net decline across the window.
Abbott Laboratories capital expenditures peaked at $2.21B in 2024; the latest annual figure is $2.17B in 2025 (1.6% below peak).
Across the available history, capital expenditures reached its high of $2.21B in 2024 and its low of $0 in 1993.
Among 8 Healthcare peers, Abbott Laboratories (ABT) ranks 7th; the peer median for capital expenditures is $3.87B.
Abbott Laboratories Capital Expenditures by Year
Abbott Laboratories Capital Expenditures 2025: $2.17B
Abbott Laboratories capital expenditures in 2025 was $2.17B, edged down 1.6% below 2024.
Abbott Laboratories Capital Expenditures 2024: $2.21B
Abbott Laboratories capital expenditures in 2024 was $2.21B, edged up 0.2% from 2023. This figure represents the highest annual value in the available history.
Abbott Laboratories Capital Expenditures 2023: $2.20B
Abbott Laboratories capital expenditures in 2023 was $2.20B, grew 23.9% from 2022.
Abbott Laboratories Capital Expenditures 2022: $1.78B
Abbott Laboratories capital expenditures in 2022 was $1.78B, declined 5.7% below 2021.
Abbott Laboratories Capital Expenditures 2021: $1.89B
Abbott Laboratories capital expenditures in 2021 was $1.89B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — CapEx
Companies in the same sector as Abbott Laboratories, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's capital expenditures?
- Latest reported capital expenditures for Abbott Laboratories (ABT) is $2.17B (period ending December 31, 2025).
How has Abbott Laboratories capital expenditures changed year-over-year?
- Abbott Laboratories (ABT) capital expenditures changed -1.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories capital expenditures?
- Abbott Laboratories (ABT) capital expenditures compound annual growth rate is -0.1% over the most recent 5 years available.
When did Abbott Laboratories capital expenditures hit its highest annual value?
- Abbott Laboratories capital expenditures reached its highest annual value of $2.21B in 2024.
What was Abbott Laboratories capital expenditures in 2024?
- Abbott Laboratories (ABT) capital expenditures in 2024 was $2.21B.
What was Abbott Laboratories capital expenditures in 2025?
- Abbott Laboratories (ABT) capital expenditures in 2025 was $2.17B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.